- Report
- December 2025
- 120 Pages
Global
From €5345EUR$5,950USD£4,578GBP
- Report
- April 2026
- 146 Pages
Global
From €2694EUR$2,999USD£2,308GBP
€3592EUR$3,999USD£3,077GBP
- Report
- February 2026
- 144 Pages
Global
From €2694EUR$2,999USD£2,308GBP
€3592EUR$3,999USD£3,077GBP
- Report
- July 2026
- 187 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- July 2026
- 194 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- July 2026
- 192 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- July 2026
- 198 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- July 2026
- 198 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- July 2026
- 198 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 181 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 180 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 181 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 198 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 197 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 180 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- January 2026
- 190 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- June 2026
- 197 Pages
Global
From €3185EUR$3,545USD£2,728GBP
€3539EUR$3,939USD£3,031GBP
- Report
- May 2026
- 185 Pages
Global
From €4043EUR$4,500USD£3,463GBP
- Report
- January 2026
- 180 Pages
Global
From €4043EUR$4,500USD£3,463GBP
- Report
- November 2025
- 180 Pages
Global
From €4043EUR$4,500USD£3,463GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more